178 related articles for article (PubMed ID: 37311986)
21. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
Grogg KL; Lohse CM; Pankratz VS; Halling KC; Smyrk TC
Mod Pathol; 2003 Jul; 16(7):641-51. PubMed ID: 12861059
[TBL] [Abstract][Full Text] [Related]
22. Characterization of CD66b and its relationship between immune checkpoints and their synergistic impact in the prognosis of surgically resected lung adenocarcinoma.
Shen M; Jiang K; Sui Y; Xu Z; Cui H; Wang Y; Zhang H; Xu Z; Xu W; Ding Q; Chen Y
Lung Cancer; 2021 Oct; 160():84-91. PubMed ID: 34479175
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
Front Immunol; 2021; 12():736030. PubMed ID: 34659224
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
25. LAG3 blockade coordinates with microwave ablation to promote CD8
Shao D; Chen Y; Huang H; Liu Y; Chen J; Zhu D; Zheng X; Chen L; Jiang J
J Transl Med; 2022 Sep; 20(1):433. PubMed ID: 36180876
[TBL] [Abstract][Full Text] [Related]
26. Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples.
Liu Q; Qi Y; Zhai J; Kong X; Wang X; Wang Z; Fang Y; Wang J
Front Immunol; 2021; 12():599207. PubMed ID: 34267742
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic values of stromal tumor-infiltrating lymphocytes and lymphocyte-activation gene-3 in advanced gastric adenocarcinoma].
Wu ZD; Wang JC; Zhang HJ; Lin JQ; Wu ZZ; Zheng XW; Chen G
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):1007-1012. PubMed ID: 36207914
[No Abstract] [Full Text] [Related]
28. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
[TBL] [Abstract][Full Text] [Related]
29. The Association between Blood Indexes and Immune Cell Concentrations in the Primary Tumor Microenvironment Predicting Survival of Immunotherapy in Gastric Cancer.
Yuan J; Zhao X; Li Y; Yao Q; Jiang L; Feng X; Shen L; Li Y; Chen Y
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892867
[TBL] [Abstract][Full Text] [Related]
30.
Klümper N; Ralser DJ; Bawden EG; Landsberg J; Zarbl R; Kristiansen G; Toma M; Ritter M; Hölzel M; Ellinger J; Dietrich D
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32234847
[TBL] [Abstract][Full Text] [Related]
31. Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer.
Zhang D; He W; Wu C; Tan Y; He Y; Xu B; Chen L; Li Q; Jiang J
Front Immunol; 2019; 10():71. PubMed ID: 30761139
[TBL] [Abstract][Full Text] [Related]
32. Characterization of spatial distribution of tumor-infiltrating CD8
Masugi Y; Abe T; Ueno A; Fujii-Nishimura Y; Ojima H; Endo Y; Fujita Y; Kitago M; Shinoda M; Kitagawa Y; Sakamoto M
Mod Pathol; 2019 Oct; 32(10):1495-1507. PubMed ID: 31186528
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of noggin protein expression in patients with resected gastric cancer.
Chun SH; Kim EY; Yoon JS; Won HS; Yim K; Hwang HW; Hong SA; Lee M; Lee SL; Kim SS; Sun S; Ko YH
BMC Cancer; 2021 May; 21(1):558. PubMed ID: 34001012
[TBL] [Abstract][Full Text] [Related]
34. B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer.
Sakimura C; Tanaka H; Okuno T; Hiramatsu S; Muguruma K; Hirakawa K; Wanibuchi H; Ohira M
J Surg Res; 2017 Jul; 215():74-82. PubMed ID: 28688665
[TBL] [Abstract][Full Text] [Related]
35. Digital image analysis in pathologist-selected regions of interest predicts survival more accurately than whole-slide analysis: a direct comparison study in 153 gastric carcinomas.
Heo YJ; Lee T; Byeon SJ; Kim EJ; Shin HC; Kim B; Kang SY; Ha SY; Kim KM
J Pathol Clin Res; 2021 Jan; 7(1):42-51. PubMed ID: 32885920
[TBL] [Abstract][Full Text] [Related]
36. CD226 identifies functional CD8
Huang H; Huang Z; Ge J; Yang J; Chen J; Xu B; Wu S; Zheng X; Chen L; Zhang X; Jiang J
Front Immunol; 2023; 14():1150803. PubMed ID: 37056782
[TBL] [Abstract][Full Text] [Related]
37. Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients.
Brück O; Lee MH; Turkki R; Uski I; Penttilä P; Paavolainen L; Kovanen P; Järvinen P; Bono P; Pellinen T; Mustjoki S; Kreutzman A
Mod Pathol; 2021 Dec; 34(12):2229-2241. PubMed ID: 34215851
[TBL] [Abstract][Full Text] [Related]
38. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
39. Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer.
Kim Y; Rhee YY; Wen X; Cho NY; Bae JM; Kim WH; Kang GH
Gastric Cancer; 2020 May; 23(3):464-472. PubMed ID: 31691036
[TBL] [Abstract][Full Text] [Related]
40. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
